I Wouldn't Back Up the Truck for Nikola Stock Right Now
While I like getting involved in volatility, I don't see any edge here, only the potential to see things go ... rolling down hill.
China's Kingold Jewelry Allegedly Used Fake Gold to Secure Huge Loans
Lenders to the Nasdaq-listed jewelry maker reportedly have discoverd that 83 tons of gold used to borrow billions appear to be copper alloy bars.
Acreage Probe Leads Company to Reform Massachusetts Deals
Cannabis player came under scrutiny for number of store licenses in state.
Jim Cramer: The Earth's New Cop? The Microsoft Protection Agency
While the president is pushing coal, this corporate giant is stepping up to cut the carbon cord.
Under Armour Loses Traction and Puts Chart Support Into Question
Shares of the shoe and apparel maker are reacting to reduced revenue guidance and word of government investigations into its accounting practices.
The Cannabis Sector and Its Dot-Com Like Meltdown
Black-market vaping has made the entire cannabis group toxic.
Have Those Once-Smoking Cannabis Stocks Burnt Down to a Bottom?
Several watchers and market players are deep in the weeds, tracking short action and key companies like Canopy Growth, trying to find out whether the industry has turned over a new leaf.
These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared
Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.
M&A Appetite in Pharma Has Proved Potent: Chart of the Day
With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.